Locations:
Search
Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches
Multidisciplinary teams bring pathological and clinical expertise
Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy
AI-driven tools can streamline enrollment and improve efficiency across clinical trials.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Patient achieves complete remission from aggressive marginal zone lymphoma with liso-cel
A multi-pronged strategy for tackling cancer access problems
Early results show patients experiencing deep and complete response
Phase 3 trial found no survival differences between weekly or biweekly doxorubicin/cyclophosphamide or between weekly or biweekly paclitaxel
Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates
Cleveland Clinic Cancer Institute takes multi-faceted approach to ensuring clinical trials representation
Advertisement
Advertisement